Cargando…
Prevalence and types of persistent dyslipidemia in patients treated with statins
AIM: To determine the prevalence and types of persistent dyslipidemia in patients treated with different statins to reduce cardiovascular disease (CVD) risk, as well as to determine the proportion of high risk patients who did not reach the lipid target values and assess cardiologists' further...
Autores principales: | Reiner, Željko, Tedeschi-Reiner, Eugenia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760657/ https://www.ncbi.nlm.nih.gov/pubmed/23986274 http://dx.doi.org/10.3325/cmj.2013.54.339 |
Ejemplares similares
-
Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases
por: Mansouri, Atena, et al.
Publicado: (2022) -
The perception and knowledge of cardiovascular risk factors among medical students
por: Reiner, Željko, et al.
Publicado: (2012) -
New Drugs for Treating Dyslipidemia: Beyond Statins
por: Ahn, Chang Ho, et al.
Publicado: (2015) -
Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study
por: Azar, Sami T, et al.
Publicado: (2014) -
Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia
por: Banach, Maciej, et al.
Publicado: (2021)